Agentase LLC Contract Details

Defense contract under the Defense Advanced Research Projects Agency awarded to Agentase LLC on 1/14/2014.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: Agentase LLC
Department: Defense Advanced Research Projects Agency
Awarded: 1/14/2014

Agentase LLC, Pittsburgh, Pa., has been awarded an $11,206,720 cost contract. The work will support the DARPA’s In Vivo Nanoplatforms program (IVN). IVN seeks to develop new classes of adaptable nanoparticles for persistent, distributed, unobtrusive physiologic and environmental sensing as well as the treatment of physiologic abnormalities, illness and infectious disease. Work will be performed in Pittsburgh, Pa., (44.59 percent); Cambridge, Mass., (8.04 percent); Davis, Calif., (40.92 percent) and College Station, Texas, (6.45 percent). The estimated completion date is April 14, 2015. Fiscal 2013 research and development funds are being obligated at time of award. The contracting activity is DARPA, Arlington, Va., (HR0011-14-C-0030).

Total Contract Value: $11,206,720

View all contracts that include "Agentase LLC" in the MiC database.